Abstract The coronavirus disease 2019 (COVID-19) pandemic, along with the
implementation of public health and social measures (PHSMs), have markedly reshaped …

Nationwide nonpharmaceutical interventions (NPIs) have been effective at mitigating the
spread of the novel coronavirus disease (COVID-19), but their broad impact on other …

Abstract Background Various nonpharmaceutical interventions (NPIs) against COVID-19
continue to have an impact on socioeconomic and population behaviour patterns. However …

Background The long-term impact of COVID-19-associated public health interventions on
zoonotic and vector-borne infectious diseases (ZVBs) remains uncertain. This study sought …

Background: COVID-19 was first reported in 2019, and the Chinese government
immediately carried out stringent and effective control measures in response to the …

Abstract Background: Nonpharmaceutical interventions (NPIs) are public health measures
that aim to suppress the transmission of infectious diseases, including border restrictions …

The outbreak of coronavirus disease 2019 (COVID-19) has not only posed significant
challenges to public health but has also impacted every aspect of society and the …

Background: By February 2021, the overall impact of coronavirus disease 2019 (COVID-19)
in South and Southeast Asia was relatively mild. Surprisingly, in early April 2021, the second …

Background China managed coronavirus disease 2019 (COVID-19) with measures against
Class B infectious diseases, instead of Class A infectious diseases, in a major shift of its …

Background The ongoing benefits of coronavirus disease 2019 (COVID-19)
nonpharmaceutical interventions (NPIs) for respiratory infectious diseases in China are still …